Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are produced by pituitary gonadotrope cells and are required for steroidogenesis, the maturation of ovarian follicles, ovulation, and spermatogenesis. Synthesis of LH and FSH is tightly regulated by a complex network of signaling pathways activated by hormones including gonadotropin-releasing hormone, activin and sex steroids. Members of the forkhead box (FOX) transcription factor family have been shown to act as important regulators of development, homeostasis and reproduction. In this review, we focus on the role of four specific FOX factors (FOXD1, FOXL2, FOXO1 and FOXP3) in gonadotropin hormone production and discuss our current understanding of the molecular function of these factors derived from studies in mouse genetic and cell culture models.
Introduction to forkhead transcription factors
The forkhead box (FOX) gene family of transcription factors consists of over 100 proteins that have been divided into subfamilies ranging from FOXA to FOXS (Hannenhalli and Kaestner, 2009 ).
The family is named after the forkhead transcription factor that was identified in Drosophila melanogaster, which, when mutated, gave the insect embryo a distinctive spiked or fork-headed appearance (Weigel et al., 1989) . FOX proteins have been characterized in eukaryotes such as yeast, tunicates, nematodes, fish, amphibians, birds, and mammals including humans. Expansion of FOX proteins occurred early in eukaryotic evolution with all bilaterans having at least 19 FOX genes and mammals having over 40 (Jackson et al., 2010) .
All FOX proteins contain a highly conserved DNA binding domain (DBD) that is $100 amino acids in length (Jackson et al., 2010) . This forkhead DBD has a winged helical structure composed of three alpha helices and two butterfly-like wings when bound to DNA. FOX proteins have similar binding specificity to a core sequence [T(A/G)TT(T/G)] but different subfamilies recognize diverse DNA sequences adjacent to the core sequence (Wijchers et al., 2006) . In contrast to the DBD, the amino and carboxyl-terminal domains of FOX proteins diverge widely, likely reflecting the function of these proteins in a wide variety of key biological processes including development, proliferation, differentiation, stress resistance, apoptosis, metabolism, and reproduction. Although a potential role for FOX proteins in reproduction was suggested by altered fertility in Caenorhabditis elegans mutants of DAF-16 (a FOXO homolog) (Tissenbaum and Ruvkun, 1998) , it is only in the past decade that we have begun to understand how FOX proteins regulate production of mammalian gonadotropin hormones.
The gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), are produced exclusively in the gonadotrope cells of the anterior pituitary and secreted into the blood where they regulate steroidogenesis and gametogenesis in the gonads (Burns and Matzuk, 2002) . LH and FSH are synthesized in response to hormones, such as gonadotropin-releasing hormone (GnRH), activin and gonadal steroids (Seeburg et al., 1987; Vale et al., 1977) . LH and FSH are dimeric glycoproteins composed of a common chorionic gonadotrophin alpha subunit (CGA) and a unique beta subunit (LHB or FSHB) (Pierce and Parsons, 1981) . Cga mRNA is first expressed in the developing murine pituitary at embryonic day (e) 11.5, Lhb at e16.5, and Fshb at e17.5 (Japon et al., 1994) . In this review, we discuss the function and molecular mechanisms of four specific FOX factors that have been reported to regulate gonadotropin gene expression: FOXD1, FOXL2, FOXO1, and FOXP3.
FOXD1
FOXD1 (FREAC-4) was originally reported to be highly expressed in the kidney and testis while the mouse homolog was identified in the brain as brain-factor-2 (Hatini et al., 1994; Pierrou et al., 1994) . Foxd1 knockout mice have undeveloped kidneys and die within 24 h after birth due to renal failure (Hatini et al., 1996; Levinson et al., 2005) . FOXD1 is also expressed in the retina and is necessary for normal development of the retina and optic chiasm (Herrera et al., 2004) . While not much is known about the functions of the amino and carboxyl-terminal regions of FOXD1, the forkhead domain of FOXD1 ( Fig. 1 ) was reported to bind to a core consensus RTAAYA motif (Pierrou et al., 1994) .
Although Foxd1 was reported in an expression library derived from e14.5 pituitary, b-galactosidase was not observed in the developing pituitary gland of mice in which Foxd1 was replaced with lacZ (Gumbel et al., 2012) . On the other hand, b-galactosidase was detected in the mesenchyme surrounding the pituitary at e10.5 and e14.5 (Gumbel et al., 2012) . This discrepancy may be explained by the presence of mesenchyme in the dissected e14.5 pituitaries in the expression library. Gumbel et al. also asked whether FOXD1 was important for gonadotropin gene expression (Gumbel et al., 2012) . In contrast to Cga and Fshb mRNA levels, levels of Lhb were significantly decreased in Foxd1 knockout mice at e18.5 compared to wild-type littermates. In addition, the intensity of LHB staining was reduced in the Foxd1 knockout mice while the number of LHB-positive cells remained the same, indicating that decreased Lhb expression was not due to impaired gonadotrope differentiation. Since FOXD1 is not expressed in the pituitary, rather in the mesenchyme surrounding the pituitary, the reduction in Lhb expression may be due to loss of signaling factors from the mesenchyme. Factors, such as fibroblast growth factor or bone morphogenetic protein, are expressed in the mesenchyme and have been reported to regulate the amount of CGA and adrenocorticotropic hormone (ACTH) (Ericson et al., 1998) . It will be interesting to determine in future studies what factors in the pituitary mesenchyme are regulated by FOXD1 and how they, in turn, regulate Lhb gene expression.
FOXL2
FOXL2 is a single exon gene expressed in the developing eyelid, pituitary and ovary. Humans with mutations in FOXL2 develop Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) which is an autosomal dominant disorder characterized by distinctive eyelid abnormalities. Two clinical subtypes have been described; type I is associated with premature ovarian failure (Crisponi et al., 2001 ). Knockout of Foxl2 in mice recapitulated the human syndrome and demonstrated that Foxl2 is required for ovarian granulosa cell differentiation and proliferation as well as female sex determination (Uhlenhaut and Treier, 2011) . Like other FOX proteins, FOXL2 contains a forkhead DBD (Fig. 1 ) that recognizes a conserved core sequence or a specific high-affinity FOXL2 binding element (FLRE) (Benayoun et al., 2008b) . FOXL2 also has a unique 14 amino acid polyalanine tract in the carboxyl-terminal region which is a mutational hotspot in BPES patients (Verdin and De Baere, 2012) . Interestingly, a somatic C402G mutation in the FOXL2 DBD has been found in over 95% of adult granulosa cell tumors (Verdin and De Baere, 2012) .
In mice, FOXL2 has been reported to be expressed relatively early in pituitary gland development at e10.5 and e12.5 (Dasen et al., 1999; Treier et al., 1998) and at e11.5, coincident with CGA (Ellsworth et al., 2006) . Once induced, FOXL2 expression in the pituitary is maintained throughout embryonic development and into adulthood. FOXL2 is expressed in gonadotropes and thyrotropes but not in corticotropes, somatotropes or lactotropes (Blount et al., 2009; Ellsworth et al., 2006) . In agreement with the in vivo data in mice, FOXL2 is expressed in immortalized cell lines that represent gonadotropes at different stages of development, such as aT3-1 and LbT2 cells (Blount et al., 2009; Ellsworth et al., 2006) . FOXL2 is expressed in non-proliferating cells during development (Ellsworth et al., 2006) , suggesting that this factor may play a role in cellular differentiation. However, knockout of Foxl2 in mice results in a hypoplastic pituitary that has a similar proportion of the endocrine cell types in the anterior pituitary (Justice et al., 2011) , indicating that FOXL2 is not required for pituitary cell type specification.
Foxl2 knockout mice have a high percentage of embryonic lethality (50-95%) and the majority of surviving mice die at 3-5 weeks of age. Not surprisingly, given the role of Foxl2 in the ovary (Schmidt et al., 2004; Uda et al., 2004) , the surviving female mice have severe ovarian defects as well as impaired gonadotropin hormone production (Justice et al., 2011) . To test the hypothesis that FOXL2 is required for FSH synthesis, Tran et al. generated a conditional knockout of Foxl2 in the pituitary using a cre recombinase knocked into Gnrhr (GRIC-Cre) (Wen et al., 2008) crossed to a floxed Foxl2 mouse (Uhlenhaut et al., 2009 ). In this model, female mice were subfertile with decreased ovarian weight and ovulation rates while males were subfertile with decreased testis size and sperm counts Both models had substantially decreased Fshb mRNA and serum FSH levels (Justice et al., 2011; Tran et al., 2013) .
Dispersed primary pituitary cells from both Foxl2 knockout models also had significantly reduced activin induction of Fshb (Justice et al., 2011; Tran et al., 2013) . Activin is a critical regulatory component of Fshb synthesis and the amount of bioavailable activin fluctuates during the estrous cycle due to changes in intrapituitary follistatin and ovarian inhibin levels (Besecke et al., , 1997 Woodruff et al., 1996) . Activin signaling in gonadotrope cells through type II and type I receptors (ActRII A/B and activin receptor-like kinases 4/7) results in the phosphorylation of receptorassociated SMAD2/3 (Bernard, 2004; Dupont et al., 2003; Norwitz et al., 2002) . Upon phosphorylation, SMAD2/3 bind to SMAD4 and translocate into the nucleus of gonadotropes (Norwitz et al., 2002) where they regulate gene expression as a heterodimer or in combination with other transcription factors. SMAD3/4 can bind DNA directly through a defined Smad-binding element (SBE) (GTC-TAG[N]C) or a SMAD half site (GTCT). In addition to SMAD proteins, analysis of mammalian FSHB promoters in LbT2 cells demonstrated that the FOXL2 transcription factor is essential for activin induction of murine, porcine and human FSHB gene expression [recently reviewed in Bernard et al. (2010) , Bernard and Tran (2013) , Coss et al. (2010) ]. SiRNA knockdown of Foxl2 in LbT2 cells substantially decreased activin induction of a luciferase reporter linked to the Fshb promoter as well as endogenous Fshb mRNA levels (Lamba et al., 2009; Tran et al., 2011) . Mutation of the FOXL2 DNA binding domain also resulted in reduced activin induction of the Fshb promoter, indicating that FOXL2 DNA binding was required for its effect (Tran et al., 2011) .
Several FOXL2 binding elements (FBE) in the Fshb promoter have been characterized to date (Fig. 2) . Mutation of a SMAD half site at À116/À113 in the murine Fshb promoter resulted in almost a complete lack of activin responsiveness (Bailey et al., 2004) . This SBE was shown to bind SMAD2/3/4 (Bailey et al., 2004; McGillivray et al., 2007) . FOXL2 binds to a FBE overlapping this site at À113/ À108 (Fig. 2 ) and mutation of A-108G resulted in a profound reduction in activin response (Lamba et al., 2009; Tran et al., 2011) . Mutation of a SMAD half site at À149/À146 also resulted in decreased activin responsiveness (Bailey et al., 2004) . SMAD binding at this site was only detected using overexpression of the MH1 domain of SMADs in a gel-shift assay, suggesting that this is a low affinity site (Tran et al., 2011 ). An overlapping FBE site at À154/À149 was reported to bind FOXL2 with a much higher affinity in the porcine promoter than the human or murine promoters due to one or two base-pair changes, respectively ( Fig. 2) (Corpuz et al., 2010; Lamba et al., 2009) . Although mutation of the SBE disrupted FOXL2 binding (Corpuz et al., 2010) , it is uncertain whether this FBE is necessary for activin responsiveness on the murine promoter since a TTT-142GGG mutation just outside this site significantly reduced activin induction (Corpuz et al., 2010) while a TT-152GG mutation within this site only had a modest effect (Tran et al., 2011) .
In contrast to the two FBEs described above that are conserved amongst different mammalian species, the murine promoter contains another FBE at À350/À341 that binds FOXL2 with high affinity (Fig. 2) (Corpuz et al., 2010) . Mutation of this element had a substantial effect on activin responsiveness (Corpuz et al., 2010; Tran et al., 2011) as well as synergy between activin and progestins (Ghochani et al., 2012) . Interestingly, there is also a rodent-specific consensus SBE at À267/À260 that is required for maximal activin responsiveness (Gregory et al., 2005; Lamba et al., 2006; Suszko et al., 2003) and a putative SBE at À355/À352. Mutation of the À355/À352 SBE altered the responsiveness of the murine Fshb promoter to SMAD3 overexpression and synergy between activin and progestins (Corpuz et al., 2010; Ghochani et al., 2012) . Since the murine, porcine and human promoters all contain the proximal FBE and SBE, the sensitivity of the murine Fshb promoter to activin may be due to the rodent-specific distal FBE and SBEs while the porcine promoter may be highly responsive to activin due to the central high affinity FBE.
In addition to regulating Fshb gene expression, FOXL2 may also regulate expression of the GnRH receptor (Gnrhr) and Cga. Activin induction of murine Gnrhr in aT3-1 cells mapped to a composite GnRH activating sequence (GRAS) in the proximal promoter that contains SMAD, activator protein 1 (AP1) and FOXL2 binding sites Ellsworth et al., 2003) . Mutation of the 3 0 end of GRAS had little effect on SMAD or AP1 binding to the Gnrhr promoter but had an effect on activin responsiveness. Although the specific base pairs necessary for FOXL2 to bind this element remain to be determined, overexpression of a FOXL2-VP16 fusion protein induced a multimer of the GRAS element and required the FBE to do so (Ellsworth et al., 2003) . In regards to CGA, overexpression of FOXL2 or FOXL2-VP16 was shown to stimulate Cga gene expression in LbT2 cells (Ellsworth et al., 2006) . It is unknown whether this occurs through binding of FOXL2 to the Cga promoter. A FOXL2-VP16 transgenic mouse also expressed CGA in a similar spatial pattern to the fusion protein (Ellsworth et al., 2006) . However, it is not clear whether FOXL2 is necessary for regulation of Gnrhr or Cga transcription in vivo since Gnrhr and Cga mRNA levels were decreased in female Foxl2 KO (Justice et al., 2011) but were unchanged in the gonadotrope-specific Foxl2 KO mouse model .
FOXL2 has also been reported to regulate transcription of follistatin, an activin bioneutralizing protein, through a FBE located in the first intron of the follistatin gene (Blount et al., 2009 ) that is quite similar in sequence to the FLRE (Benayoun et al., 2008b) .
Although it remains to be demonstrated what base pairs are required for FOXL2 binding to this element, this FBE and the adjacent SBE in the intronic enhancer are required for activin induction of follistatin transcription since mutation of either reduced activin responsiveness (Blount et al., 2009 (Blount et al., , 2008 . SiRNA knockdown of FOXL2 in aT3-1 cells also significantly decreased activin induction of follistatin (Blount et al., 2009) . In agreement with the cell culture studies, follistatin mRNA levels were decreased in both the global and gonadotrope-specific Foxl2 knockout mice levels (Justice et al., 2011; Tran et al., 2013) . It is interesting to note that FOXL2 does not appear to be expressed in S100-positive folliculostellate cells which also express follistatin (Blount et al., 2009 ). This may be a mechanism to restrict the effects of activin on follistatin production to gonadotrope cells.
So how does FOXL2 function in the activin induction of gonadotropin genes? One possibility is that activin signaling results in phosphorylation and translocation of SMAD proteins into the nucleus, where they partner with FOXL2 to regulate transcription of specific target genes. Presently, it is unclear whether FOXL2 is constitutively bound to DNA or recruited following activin treatment. DNA pulldown and chromatin immunoprecipitation experiments showed that FOXL2 can bind to the Fshb proximal promoter or the follistatin intronic enhancer without activin treatment, although FOXL2 binding to the follistatin enhancer was enhanced with activin (Blount et al., 2009; Corpuz et al., 2010) . It is also becoming apparent that FOXL2 interaction with SMAD proteins may be necessary for activin transcriptional regulation. As noted previously, FOXL2 binding sites in the Fshb, follistatin and Gnrhr promoters are adjacent to a SBE. Additionally, a FBE and SBE multimer is sufficient for activin responsiveness, in contrast to a FBE multimer on its own (Corpuz et al., 2010) . FOXL2 was also reported to interact with SMAD3 in a mammalian two-hybrid system and in co-immunoprecipitation experiments in HEK293 cells (Blount et al., 2009; Ellsworth et al., 2003) . FOXL2 was also shown to associate with endogenous SMAD2/3 in gonadotrope cells . Although the FOXL2 DBD and the SMAD3 carboxyl-terminal MH2 domain are required for interaction, it is not known how interactions between these two proteins facilitate DNA binding and transcriptional activation. Since FOXL2 has been reported to be post-translationally modified (Benayoun et al., 2008a) and phosphorylated by a serine/threonine kinase, LATS1 in ovarian granulosa cells (Pisarska et al., 2010) , it is also possible that activin signaling in gonadotropes may regulate FOXL2 activity through an as yet unidentified kinase. Thus, a decade of investigating the role of FOXL2 in gonadotropin hormone regulation has provided many insights and left us with new questions regarding FOXL2 action in gonadotropes.
FOXO1
The FOXO subfamily of transcription factors consists of 4 genes in mammals: FOXO1 (alternatively known as FKHR), FOXO3 (FKHRL1), FOXO4 (AFX) and FOXO6 (Burgering, 2008; Jacobs et al., 2003) . FOXO1 was originally identified as a chromosomal translocation in human alveolar rhabdomyosarcomas (Anderson et al., 1998) . FOXOs have been shown to be key regulators of cellular pathways involved in apoptosis, stress resistance, cell cycle arrest and DNA damage repair (Accili and Arden, 2004; Greer and Brunet, 2005) . They also have important roles in metabolism, homeostasis and reproduction. Knockout of Foxo4 in mice had no overt phenotype, suggesting functional redundancy between FOXO4 and FOXO1/3 (Hosaka et al., 2004) . Foxo3 knockout mice have an age-dependent reduction in fertility caused by defective ovarian follicular growth, similar to premature ovarian failure in women (Castrillon et al., 2003) . Foxo1 knockout mice die at e10.5 due to a lack of vascularization (Hosaka et al., 2004) . However, conditional knockouts of Foxo1 have demonstrated that FOXO1 plays a role in ovarian granulosa cell proliferation and apoptosis, along with FOXO3 and that FOXO1 is essential for maintenance and differentiation of spermatogonial stem cells in the testis (Goertz et al., 2011; Liu et al., 2013) .
Like the other FOX proteins, FOXOs contain a highly conserved forkhead DBD (Fig. 1) . The structures of FOXO1, FOXO3 or FOXO4 bound to DNA have been solved (Boura et al., 2010; Brent et al., 2008; Tsai et al., 2007) . These structures indicate that FOXO target gene expression is probably regulated in a differential manner due to variations in the affinity for different DNA response elements. FOXO proteins recognize two 8 base pair sequences distinct from a core forkhead consensus sequence: the insulin response element present in the IGFBP1 promoter [TT(A/G)TTTTG] and the DAF-16 family binding element [TT(G/A)TTTAC] (Furuyama et al., 2000; Tang et al., 1999) . FOXOs also contain a nuclear localization signal (NLS), a nuclear export sequence (NES) and a carboxyl-terminal transactivation domain (Obsil and Obsilova, 2008; Tzivion et al., 2011) .
The activity of FOXOs is tightly controlled by post-translational modifications including phosphorylation, acetylation and ubiquitination (Calnan and Brunet, 2008) . Activation of insulin and growth factor signaling pathways negatively regulate FOXOs through phosphorylation of three conserved residues by the AKT serine/ threonine kinase, resulting in their active nuclear export and inhibition of their transcriptional activities (Van Der Heide et al., 2004) . Phosphorylation of FOXOs by other kinases, such as c-jun N-terminal kinase, in response to stress, results in their translocation to the nucleus (Essers et al., 2004; Kops et al., 2002) . Studies have also demonstrated that FOXOs can be acetylated by CBP/p300 and deacetylated by sirtuins such as SIRT1 (Brunet et al., 2004; van der Horst et al., 2004) .
Intriguingly, deletion of Foxo1 and Foxo3 in the somatic tissues of adult female mice resulted in pituitary adenomas, suggesting that FOXO proteins may play important roles within the pituitary gland (Paik et al., 2007) . Although the expression of FOXOs in human pituitary has not yet been characterized, FOXO1 expression was reported to be down regulated in human pituitary null cell and gonadotrope adenomas (Michaelis et al., 2011) . FOXO1 is also expressed in the developing and adult murine pituitary (Nakae et al., 2008; Villarejo-Balcells et al., 2011) . More recently, Arriola et al. showed FOXO1 expression in adult murine gonadotropes and thyrotropes as well as in immortalized cell lines that represent these cell types such as the aT3-1, LbT2 and TaT-1 cell lines (Arriola et al., 2012) . Dual label immunofluorescence was performed to determine whether other hormone-producing cell types in the anterior pituitary express FOXO1 and FOXO3 (Fig. 3) . As previously reported, FOXO1 colocalized with >95% LHB-containing gonadotropes and thyroid stimulating hormone beta (TSHB)-containing thyrotropes (Fig. 3A) . FOXO1 was not expressed in somatotropes, lactotropes or corticotropes containing growth hormone (GH), prolactin (PRL) or ACTH, respectively. FOXO1 expression was also not observed in AtT20 cells, derived from an ACTH-secreting mouse pituitary tumor (data not shown). In contrast, FOXO3 colocalized with TSHB-containing thyrotropes and ACTH-containing corticotropes but not with gonadotropes, somatotropes or lactotropes containing LHB, GH or PRL, respectively (Fig. 3B) .
It should be noted that the restriction of FOXO1 expression to adult murine gonadotrope cells was not observed in another study. In this report, FOXO1 was detected in a subset of cells within the anterior pituitary (7% of adult murine gonadotropes, 9% thyrotropes, 15% lactotropes, 30% corticotropes and 63% somatotropes) (Majumdar et al., 2012) . At this time, it is not clear why there is a discrepancy between the two reports. It seems unlikely that mouse strain differences account for the discrepancy since both studies used C57BL/6 mice. Whether the sex or age of the mice influences FOXO1 expression in the anterior pituitary remains to be determined. We have determined that both FOXO1 antibodies used in the immunofluorescence studies (11350, Santa Cruz Biotechnology and 2880, Cell Signaling Technology) detect the same full-length FOXO1 protein ($82 kDa) in western blot analysis of proteins derived from LbT2 cells as well as pituitaries from male and female C57BL/6 mice (data not shown). One difference we have noted is that the signal from the FOXO1 2880 antibody is extremely faint in immunofluorescence experiments using paraffinembedded pituitary sections.
Since the Foxo1 mouse knockout is embryonic lethal, it is not known whether FOXO1 is required for gonadotropin gene expression in vivo. Analysis of a Foxo1 conditional knockout in pituitary gonadotropes in my laboratory using the GRIC-Cre mouse (Wen et al., 2008) crossed to a floxed FOXO1 mouse (Paik et al., 2007) should help answer this question. In the meantime, we have used immortalized LbT2 cells to study the function of FOXO1 in gonadotropes. We found that insulin signaling via PI3K resulted in phosphorylation of FOXO1 and export of FOXO1 from the nucleus to the cytoplasm (Arriola et al., 2012) , indicating that the canonical PI3K/AKT/FOXO1 signaling pathway is intact in gonadotropes. We also demonstrated that overexpression of FOXO1, or a constitutively active FOXO1 that cannot be phosphorylated and exported into the cytoplasm, in LbT2 cells resulted in significantly decreased basal and GnRH-induced Lhb mRNA (Arriola et al., 2012) . The suppressive effect of FOXO1 was shown to occur on both the rat 1.8 kb and human 1 kb LHB promoters, suggesting that the effect may be conserved in mammals.
So how does FOXO1 act as a repressor of Lhb gene expression? Several basal transcription factors including specific protein 1, steroidogenic factor 1 (SF1) and paired-like homeodomain transcription factor (PITX1) synergize with early growth response protein 1 (EGR1) induced by GnRH signaling to up-regulate Lhb transcription (Halvorson et al., 1996; Kaiser et al., 2000; Keri and Nilson, 1996; Rosenberg and Mellon, 2002; Weck et al., 2000) . FOXO1 repression of basal and GnRH-induced Lhb transcription mapped to the proximal Lhb promoter that contains PITX1, SF1 and EGR1 binding elements (Arriola et al., 2012) . While the FOXO1 DBD appears to be required for the suppressive effect, there was no evidence that recombinant FOXO1 bound the proximal Lhb promoter. Further analysis with the native protein in gel-shift and chromatin immunoprecipitation assays may provide more insight into the mechanism of FOXO1 repression. We also found that Fig. 3 . FOXO1 is expressed in adult murine gonadotropes and thyrotropes while FOXO3 is expressed in thyrotropes and corticotropes. Adult murine pituitary tissue sections were processed and imaged at 40Â magnification, as described previously (Arriola et al., 2012) . Dual-fluorescence labeling was performed on the same section with (A) rabbit anti-human FOXO1 (H-128; Santa Cruz Biotechnology; 1:100 dilution in 10% goat serum/0.3% Triton X-100) or ( induction of Lhb due EGR1 overexpression was repressed by FOXO1 in LbT2 cells and induction of Lhb due to EGR1 plus PITX1 or SF1 expression was repressed by FOXO1 in CV-1 cells. Thus far, the data suggests that FOXO1 elicits a suppressive effect via protein-protein interactions with transcription factors necessary for Lhb synthesis.
Since some of the transcription factors necessary for Lhb synthesis also regulate Fshb transcription, we determined whether FOXO1 modulates Fshb gene expression. In a recent report, we demonstrated that overexpression of constitutively active FOXO1 or PI3K inhibition, which increases FOXO1 nuclear localization, reduced basal and GnRH-induced Fshb transcription in LbT2 or dispersed primary pituitary cells, respectively (Skarra et al., 2013) . Similarly to its action on the Lhb promoter, FOXO1 repression of Fshb mapped to the proximal promoter containing a PITX1 binding element and required the FOXO1 DBD although there was no evidence that FOXO1 bound to the proximal Fshb promoter (Skarra et al., 2013) . Additional results indicating that the mechanism of FOXO1 repression of basal Fshb transcription involves PITX1 include a physical interaction between FOXO1 and PITX1 in a GST pull-down assay that required the FOXO1 DBD as well as FOXO1 repression of PITX1 induction of the Fshb promoter in CV-1 cells (Skarra et al., 2013) . Interestingly, constitutively active FOXO1 overexpression also resulted in suppression of Pitx1 mRNA and PITX1 protein levels, indicating another potential mechanism for FOXO1 suppression of Fshb transcription. Furthermore, GnRH induction of an Fshb promoter containing a deletion at À50/À41 or À30/À21 was not repressed by FOXO1, suggesting that these two regions, one of which overlaps the PITX1 binding element, may be involved in FOXO1 suppression of GnRH-induced Fshb synthesis.
Our initial reports demonstrating FOXO1 regulation of Lhb and Fshb gene expression raise many questions. Most importantly, what is the physiological role of FOXO1 in gonadotropes? As a repressor, does it play a role in the response to pulsatile GnRH, as suggested for the Ngfi-A-binding protein family of EGR corepressors (Lawson et al., 2007) ? Is it important for the alterations in gonadotropin production observed in situations of metabolic stress? And mechanistically, how does FOXO1 act as a repressor? Are there other FOXO1 gene targets in gonadotrope cells? And is there cross-talk between GnRH and insulin signaling pathways at the level of FOXO1?
FOXP3
FOXP3 is essential for normal immune function because of its regulation of the differentiation and function of CD4 + CD25 + regulatory T cells (Lowther and Hafler, 2012) . It is expressed in the thymus and spleen as well as epithelial cells of the lung, mammary gland and prostate (Chen et al., 2008; Hori et al., 2003) . Foxp3 is located on the X chromosome in humans and mice. Mutations in human Foxp3 result in an autoimmune syndrome called immunodysregulation, polyendocrinopathy and enteropathy, X-linked (IPEX) that primarily affects males. IPEX results in severe autoimmunity, characterized by hypothyroidism, diabetes mellitus and failure to thrive that is often lethal within the first year of life (Wildin et al., 2002) . Male Foxp3 knockout mice and mice with a spontaneous mutation in Foxp3 that results in a truncated protein lacking the DBD called scurfy also have an IPEX-like syndrome (Khattri et al., 2003) . The FOXP3 forkhead domain is different from other FOX family members in that it is located near the carboxylterminus of the protein instead of the amino terminus (Fig. 1) . It also contains a proline rich domain in the amino terminus which is responsible for transcriptional repression as well as a centrally located zinc finger and leucine zipper domain which facilitates the formation of FOXP3 dimers or association with other transcription factors (Deng et al., 2012) . In addition to the IPEX-like syndrome, male scurfy mice are hypogonadal and infertile (Godfrey et al., 1991) . One recent study investigated whether FOXP3 is necessary for gonadotropin gene expression in adult male scurfy mice. Although scurfy mice die early, they can be kept alive for 6-9 weeks if they are not weaned. Jung et al. found that male scurfy mice had decreased Lhb, Fshb, Cga and Gnrhr mRNA levels . LHB and CGA protein levels were also reduced, suggesting that these mice are hypogonadotropic. Since Cga was reduced but Tshb mRNA was increased, it would be interesting to determine if changes in the pituitary translated into altered LH, FSH and TSH serum levels.
Jung et al. then looked to see if FOXP3 is expressed in the hypothalamus or pituitary but could not detect any Foxp3 mRNA using RT-PCR in either tissue . Even though Foxp3 was not detected in the hypothalamus, it is possible that GnRH production is affected indirectly by FoxP3 so the authors examined whether Gnrh expression was altered in the scurfy mice. Although no statistical difference in Gnrh expression was detected, this may be due to the high degree of variability in GnRH expression observed in the control animals. A trend towards decreased Gnrh could indicate that GnRH production was impaired in the scurfy mice. To further address this question, Jung et al. tested whether Fshb and Lhb expression were rescued after treatment with Dala-6-GnRH for 2 days . GnRH treatment did not restore Fshb and Lhb mRNA levels, suggesting that GnRH production was not altered in the scurfy mice and indicating that the defect may be at the level of the pituitary. A caveat to this experiment is that a longer treatment paradigm may be necessary to see an effect. On the other hand, a significant decrease in pituitary expression of Gnrhr was observed, indicating that GnRH production could be impaired in the scurfy animals since GnRH has been reported to positively regulate synthesis of its receptor in gonadotrope cells (McCue et al., 1997; Norwitz et al., 1999; White et al., 1999) .
Since scurfy mice suffer from autoimmunity, it is possible that the pituitary gonadotrope cells were destroyed by the immune system, similarly to the pancreatic beta cells (Lahl et al., 2007) . However, equivalent levels of SF1 mRNA and protein were detected in scurfy mice compared to controls, indicating that normal numbers of gonadotropes were present in the scurfy mice . Since Tshb mRNA levels were increased in the scurfy mice but Cga was decreased, it is possible that TSH levels in the scurfy mice were lower due to reduced CGA production in the pituitary which would result in a lack of negative T4 feedback and increased Tshb gene expression. Hypothyroidism can negatively impact gonadotropin hormone production. However, treatment of the scurfy mice with exogenous thyroid hormone resulted in decreased Tshb mRNA levels but did not restore gonadotropin gene expression (Buffy Ellsworth, personal communication), suggesting that another mechanism is responsible for the infertility.
FOXN1 is another forkhead transcription factor that is also important for immune function. A spontaneous mutation in Foxn1 called nude results in athymic, immunocompromised mice (Flanagan, 1966; Pantelouris and Hair, 1970) . It is intriguing that the infertility in the scurfy mice is rescued when the scurfy mice are bred with the nude mice (Godfrey et al., 1991) , suggesting that the infertility in the scurfy mice is due to autoimmunity. Additional evidence for this idea comes from the fact that scurfy mice have high cytokines levels due to decreased action of the regulatory T cells (Lin et al., 2005) . Since cytokines have been shown to inhibit gonadotropin hormone production (Savino et al., 1999; Wu and Wolfe, 2012) , it is possible that the infertility of the scurfy mice is secondary to their autoimmunity. Further investigation should reveal whether the hypogonadism observed in the scurfy mice is due to defects at the hypothalamic, pituitary level and/or gonadal levels as well as the molecular mechanisms that are involved.
Summary
Although the first members of the FOX transcription factor family were identified over 20 years ago, it is only in the past decade that investigators have focused on the role of FOX transcription factors in mammalian reproduction. Like the large nuclear receptor family of transcription factors, we are now beginning to appreciate the important functions of FOX transcription factors in the regulation of the hypothalamic-pituitary-gonadal axis. In this review, we focused on four FOX factors that have been reported to regulate gonadotropin hormone synthesis. Since additional FOX factors are expressed in the pituitary or regulate pituitary function, including FOXA1, FOXE1, FOXF1, and FOXG1 (Kalinichenko et al., 2003; Norquay et al., 2006; Wang et al., 2010; Zannini et al., 1997) , we anticipate many more studies concerning the regulation of gonadotropin gene expression by FOX transcription factors in the years to come.
